IN-DATE
ONYXNG25038UX: Medtronic Onyx Frontier RX Drug-Eluting Coronary Stent System (DES) 2.5mm x 38mm
Sign in to add this product to your favorites!
| Price: | $855.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 12-2027 |
| Express: | Need it tomorrow? Order in next 1 hours 26 minutes and choose overnight shipping at checkout. |
Additional Details
Medtronic Onyx Frontier Drug-Eluting Coronary Stent System (DES)
Zotarolimus-Eluting Coronary Stent System
Onyx Frontier™ is a drug-eluting stent (DES) that’s engineered to deliver, different by design, and optimized for complex percutaneous coronary intervention (PCI).
The Onyx Frontier™ DES is engineered to delivery, featuring:
- Dual-Flex Balloon
- Lower Crossing Profile
- Increased Catheter Flexibility
Onyx Frontier™ DES is different by design, featuring a single-wire design, platinum-iridium core, zotarolimus drug and BioLinx™ polymer, and a broad diameter range.
Single-Wire Design: Only Medtronic drug-eluting stents are made from a single wire, versus laser cutting, to enable a fluid range of motion for increased flexibility and the conformability needed for superior strut apposition.
The platinum-iridium core within Onyx Frontier™ DES is more visible8 than competitive DES for precise placement and follow-up treatment (while enabling greater radial strength9 with thin struts).
The zotarolimus drug inhibits neointimal growth while the BioLinx™ biocompatible polymer — the only polymer specifically designed for a DES — promotes faster healing.
AccessGUDID Info
- FDA Product Code: NIQ
- FDA Product Code Name: Coronary drug-eluting stent
- GMDN Term Code: 56284
- GMDN Term Name: Drug-eluting coronary artery stent, non-bioabsorbable-polymer-coated
- GMDN Term Description: A non-bioabsorbable metal tubular mesh structure covered with a non-bioabsorbable polymer and a drug coating that is designed to be implanted, via a delivery catheter, into a coronary artery (or saphenous vein graft) to maintain its patency typically in a patient with symptomatic atherosclerotic heart disease. The drug coating is slowly released and intended to inhibit restenosis by reducing vessel smooth muscle cell proliferation. Disposable devices associated with implantation may be included.
Manufacturer
Medtronic Cardiovascular Therapies offers a broad range of solutions for treating peripheral artery disease, aortic aneurysms, deep vein thrombosis, and other vascular conditions. Key technologies include the Endurant II and Endurant IIs stent graft systems for abdominal aortic aneurysms, the IN.PACT Admiral drug-coated balloon for femoropopliteal disease, and the Abre venous self-expanding stent system for iliofemoral venous outflow obstruction. With a commitment to advancing minimally invasive therapies, Medtronic’s vascular innovations help restore blood flow, reduce procedural risk, and improve quality of life for patients with complex vascular disease.
There is no valid manufacturer warranty on the products that Synergy Surgical sells. Any services provided by the original manufacturer of the products we sell are not available. However, eSutures offers a 100% money back guarantee (less shipping) on every item we sell within 30 days of purchase. For details, please see our Return Policy.
